Eric Lalanne
Directeur/Bestuurslid bij Oryzon Genomics Diagnóstico SL
Profiel
Eric Lalanne is currently a Director at Oryzon Genomics Diagnóstico SL.
He previously worked as a Director-In Vitro Diagnostics at Oryzon Genomics SA. Lalanne holds a doctorate degree from Université Paris 1 Panthéon-Sorbonne and undergraduate and graduate degrees from Université Toulouse III - Paul Sabatier.
Actieve functies van Eric Lalanne
| Bedrijven | Functie | Begin |
|---|---|---|
Oryzon Genomics Diagnóstico SL
 Oryzon Genomics Diagnóstico SL Medical SpecialtiesHealth Technology Oryzon Genomics Diagnóstico SL develops oncology diagnostic solutions. It operates as a IVD company that engages in developing and commercializing molecular diagnostics for oncology. The firm's product GynEC-DX, a molecular test for endometrial cancer detection. The company was founded in 2013 and is headquartered in Barcelona, Spain. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Eric Lalanne
| Bedrijven | Functie | Einde |
|---|---|---|
| ORYZON GENOMICS S.A. | Corporate Officer/Principal | - |
Opleiding van Eric Lalanne
| Université Toulouse III - Paul Sabatier | Graduate Degree |
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ORYZON GENOMICS S.A. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Oryzon Genomics Diagnóstico SL
Oryzon Genomics Diagnóstico SL Medical SpecialtiesHealth Technology Oryzon Genomics Diagnóstico SL develops oncology diagnostic solutions. It operates as a IVD company that engages in developing and commercializing molecular diagnostics for oncology. The firm's product GynEC-DX, a molecular test for endometrial cancer detection. The company was founded in 2013 and is headquartered in Barcelona, Spain. | Health Technology |